Merck Versus Merck: The Moniker Row Simmers In India
The legal battle between the ‘German’ Merck and the ‘US’ Merck over use of their shared moniker is unfolding in India, with Merck KGaA accusing Merck Sharp & Dohme (MSD) of “illegitimately” using “Merck” in online activity and in e-mail addresses targeting India.
You may also be interested in...
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
The head of global vaccine and plasma segments, bioprocessing, at German multinational Merck discusses key aspects around evolving vaccine manufacturing to improve the efficiency and speed of response during a pandemic. Pre-existing manufacturing platforms, the executive says, could compress process development work and fast-track scale-up.
Glenmark and Sun Pharma introduce nintedanib generics in India at a fraction of the innovator product’s price, vying for a share of the IPF market where pirfenidone currently holds sway.